HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators.

Abstract
We reviewed the clinical presentation, subsequent course, and outcome of 98 patients with alpha 1-antitrypsin deficiency seen at our institution during the past 20 years to obtain answers to the following questions: (1) What prognostic factors aid in determining the course of liver disease in affected patients? (2) When is the appropriate time for referral to a liver transplant center? (3) Does breast-feeding prevent chronic liver disease? (4) What is the incidence of severe liver disease in family members? Our analysis revealed that the initial values of alanine aminotransferase, prothrombin time, and trypsin inhibitory capacity may have prognostic value. During clinical follow-up the recurrence or persistence of hyperbilirubinemia along with deteriorating results of coagulation studies indicated the need for liver transplantation because of imminent poor outcome. Girls had a worse prognosis than boys. Initial breast-feeding versus feeding of commercial formulas did not influence overall overcome. The incidence of significant liver disease among "at risk" siblings was 21% (3/14); if one assumes mendelian inheritance from heterozygous parents, the overall risk for siblings in our families was 5%.
AuthorsE Ibarguen, C R Gross, S K Savik, H L Sharp
JournalThe Journal of pediatrics (J Pediatr) Vol. 117 Issue 6 Pg. 864-70 (Dec 1990) ISSN: 0022-3476 [Print] United States
PMID2246682 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Alanine Transaminase
  • Bilirubin
Topics
  • Adolescent
  • Alanine Transaminase (blood)
  • Bilirubin (blood)
  • Breast Feeding
  • Child
  • Child, Preschool
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Liver Diseases (blood, epidemiology, genetics)
  • Metabolism, Inborn Errors (blood, epidemiology, genetics)
  • Predictive Value of Tests
  • Prognosis
  • Prothrombin Time
  • Risk Factors
  • Sex Factors
  • alpha 1-Antitrypsin Deficiency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: